350 medtech venture capital firms in the US
We list 350 medtech venture capital firms in the US as of November 2026: 348 have an SEC filing on file and 2 were checked on the firm's own website or an official register, and the list was last checked on 6 Nov 2026. The cities with the most head offices on this list are New York (47), San Francisco (25) and Boston (19).
Top 10 medtech venture capital firms in the US, ranked by recent fund activity
Among firms with a published profile and a dated fund or deal in the last 24 months. The rule: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stated focus on the US (15: full marks when the firm names the US as where it invests, half when it says global), size of the fund on file on a log scale (15) and completeness of the public record (10). Regional focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns. The same rule orders the whole list; it is repeated in the method box.
Frist Cressey Ventures
Type: VC firm · HQ: Nashville, TN · Focus: Medtech, Healthtech · Latest activity: New deal, Oct 2026 · Fund size on file: $400M (SEC Form D, 2025)
Dated new deal in Oct 2026; $400M fund on file (SEC Form D, 2025); 64% of its observed portfolio is medtech and medical devices; names the US as where it invests; 8 named decision-makers on file.
Heinz Ventures, LLC
Type: VC firm · HQ: Memphis, TN · Stages: Pre-seed, Seed · Focus: Medtech, Healthtech · Latest activity: New deal, Aug 2026 · Fund size on file: $10M (SEC Form D, 2024)
Dated new deal in Aug 2026; $10M fund on file (SEC Form D, 2024); 100% of its observed portfolio is medtech and medical devices; names the US as where it invests; 5 named decision-makers on file.
JSTAR Capital
Type: VC firm · HQ: Austin, TX · Stages: Growth · Focus: Medtech, Healthtech, AI, Fintech · Latest activity: New fund, Aug 2026 · Fund size on file: $100M (SEC Form D, 2025)
Latest fund filing dated Aug 2026; $100M fund on file (SEC Form D, 2025); 62% of its observed portfolio is medtech and medical devices; 8 named decision-makers on file.
Khosla Ventures
Type: VC firm · HQ: Menlo Park, CA · Stages: Pre-seed, Seed, Series A, Growth · Focus: Medtech, AI, Consumer, B2B · Latest activity: New fund, Aug 2026 · Fund size on file: $1.9B (SEC Form D, 2025)
Latest fund filing dated Aug 2026; $1.9B fund on file (SEC Form D, 2025); states medtech and medical devices as a focus; names the US as where it invests; 8 named decision-makers on file.
Digitalis Ventures
Type: VC firm · HQ: New York, NY · Stages: Seed · Focus: Medtech, Healthtech, Biotech · Latest activity: Portfolio news, Nov 2026 · Private fund assets: $862M (SEC Form ADV)
Portfolio news dated Nov 2026; $862M on file (SEC Form ADV); states medtech and medical devices as a focus; names the US as where it invests; 8 named decision-makers on file.
Agetech Capital
Type: VC firm · HQ: Austin, TX · Focus: Medtech, Healthtech, AI, Fintech · Latest activity: New fund, Sep 2026 · Fund size on file: $3M (SEC Form D, 2026)
Latest fund filing dated Sep 2026; $3M fund on file (SEC Form D, 2026); 50% of its observed portfolio is medtech and medical devices; names the US as where it invests; 6 named decision-makers on file.
Gore Range Capital
Type: VC firm · HQ: Southlake, TX · Stages: Seed · Focus: Medtech, Healthtech, Biotech · Latest activity: New deal, Aug 2026 · Fund size on file: $250M (SEC Form D, 2026)
Dated new deal in Aug 2026; $250M fund on file (SEC Form D, 2026); states medtech and medical devices as a focus; names the US as where it invests; 1 named decision-maker on file.
Town Hall Ventures
Type: VC firm · HQ: New York, NY · Stages: Growth · Focus: Medtech, Healthtech, Impact · Latest activity: New deal, Sep 2026 · Fund size on file: $400M (SEC Form D, 2025)
Dated new deal in Sep 2026; $400M fund on file (SEC Form D, 2025); states medtech and medical devices as a focus; names the US as where it invests; 8 named decision-makers on file.
Echo Health Ventures
Type: Corporate VC · HQ: Durham, NC · Stages: Growth · Focus: Medtech, Healthtech · Latest activity: Portfolio news, Sep 2026 · Private fund assets: $518M (SEC Form ADV)
Portfolio news dated Sep 2026; $518M on file (SEC Form ADV); 77% of its observed portfolio is medtech and medical devices; 2 named decision-makers on file.
Health Velocity Capital
Type: VC firm · HQ: San Mateo, CA · Focus: Medtech, Healthtech, SaaS · Latest activity: New fund, Aug 2026 · Fund size on file: $300M (SEC Form D, 2025)
Latest fund filing dated Aug 2026; $300M fund on file (SEC Form D, 2025); states medtech and medical devices as a focus; names the US as where it invests; 5 named decision-makers on file.
First 25 of 350 medtech venture capital firms in the US
| Investor | Type | HQ | Stagesour research | Focusour research | Latest fund or deal | Fund sizeas filed or stated | Checked | Contacts |
|---|---|---|---|---|---|---|---|---|
| Frist Cressey Ventures | VC firm | Nashville, TN | Medtech, Healthtech | New deal, Oct 2026 | $400M (SEC Form D, 2025) | 4 Nov 2026 | 8 names · Unlock | |
| Heinz Ventures, LLC | VC firm | Memphis, TN | Pre-seed, Seed | Medtech, Healthtech | New deal, Aug 2026 | $10M (SEC Form D, 2024) | 4 Nov 2026 | 5 names, firm email · Unlock |
| JSTAR Capital | VC firm | Austin, TX | Growth | Medtech, Healthtech, AI, Fintech | New fund, Aug 2026 | $100M (SEC Form D, 2025) | 4 Nov 2026 | 8 names · Unlock |
| Khosla Ventures | VC firm | Menlo Park, CA | Pre-seed, Seed, Series A, Growth | Medtech, AI, Consumer, B2B | New fund, Aug 2026 | $1.9B (SEC Form D, 2025) | 4 Nov 2026 | 8 names · Unlock |
| Digitalis Ventures | VC firm | New York, NY | Seed | Medtech, Healthtech, Biotech | Portfolio news, Nov 2026 | $862M (SEC Form ADV) | 5 Nov 2026 | 8 names, firm email · Unlock |
| Agetech Capital | VC firm | Austin, TX | Medtech, Healthtech, AI, Fintech | New fund, Sep 2026 | $3M (SEC Form D, 2026) | 4 Nov 2026 | 6 names · Unlock | |
| Gore Range Capital | VC firm | Southlake, TX | Seed | Medtech, Healthtech, Biotech | New deal, Aug 2026 | $250M (SEC Form D, 2026) | 4 Nov 2026 | 1 name, firm email · Unlock |
| Town Hall Ventures | VC firm | New York, NY | Growth | Medtech, Healthtech, Impact | New deal, Sep 2026 | $400M (SEC Form D, 2025) | 5 Nov 2026 | 8 names · Unlock |
| Echo Health Ventures | Corporate VC | Durham, NC | Growth | Medtech, Healthtech | Portfolio news, Sep 2026 | $518M (SEC Form ADV) | 5 Nov 2026 | 2 names · Unlock |
| Health Velocity Capital | VC firm | San Mateo, CA | Medtech, Healthtech, SaaS | New fund, Aug 2026 | $300M (SEC Form D, 2025) | 4 Nov 2026 | 5 names · Unlock | |
| Cybernetix Ventures | VC firm | Boston, MA | Pre-seed, Seed, Series A | Medtech, Robotics, Industrial Tech, Logistics | New fund, Aug 2026 | $100M (SEC Form D, 2025) | 4 Nov 2026 | 2 names · Unlock |
| Hatteras Venture Partners | VC firm | Durham, NC | Seed | Medtech, Healthtech, Biotech | New fund, Oct 2026 | $250M (SEC Form D, 2023) | 4 Nov 2026 | 8 names · Unlock |
| 7wire Ventures | VC firm | Chicago, IL | Seed | Medtech, Healthtech, AI, SaaS | New fund, Oct 2026 | $300M (SEC Form D, 2022) | 4 Nov 2026 | 8 names · Unlock |
| Safar Partners | VC firm | Cambridge, MA | Seed | Medtech, Healthtech, Industrial Tech, Biotech | New deal, Aug 2026 | $300M (SEC Form D, 2023) | 4 Nov 2026 | 3 names, firm email · Unlock |
| Clarevia | VC firm | Madison, WI | Medtech, Healthtech, Biotech | New deal, May 2026 | $100M (SEC Form D, 2023) | 5 Nov 2026 | 8 names · Unlock | |
| HealthX Ventures | VC firm | Madison, WI | Seed | Medtech, Healthtech, AI, SaaS | New deal, Sep 2026 | $100M (SEC Form D, 2023) | 5 Nov 2026 | 8 names, firm email · Unlock |
| 1540 Ventures | VC firm | New York, NY | Medtech, Healthtech | New fund, Oct 2026 | $50M (SEC Form D, 2026) | 4 Nov 2026 | 1 name, firm email · Unlock | |
| SHD Partners | VC firm | Dallas, TX | Seed, Series A | Medtech, Healthtech, Biotech | Portfolio news, Nov 2026 | $61M (SEC Form ADV) | 5 Nov 2026 | 6 names, firm email · Unlock |
| Inspired | VC firm | New York, NY | Seed | Medtech, AI, Fintech, Generalist | New fund, Oct 2026 | $450M (SEC Form D, 2026) | 4 Nov 2026 | 8 names · Unlock |
| HC9 Ventures | VC firm | Havertown, PA | Seed, Series A | Medtech, Healthtech, AI, Fintech | New fund, Oct 2026 | $85M (SEC Form D, 2025) | 4 Nov 2026 | 3 names · Unlock |
| 25Madison Ventures | VC firm | New York, NY | Pre-seed, Seed, Series A | Medtech, Healthtech, AI, Logistics | New fund, Oct 2026 | $50M (SEC Form D, 2026) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Meridian Street | VC firm | New York, NY | Pre-seed | Medtech, Healthtech, AI, Fintech | New fund, Aug 2026 | $85M (SEC Form D, 2026) | 4 Nov 2026 | 8 names · Unlock |
| Great Oaks Venture Capital | VC firm | New York, NY | Pre-seed, Seed, Series A | Medtech, Healthtech, Generalist, SaaS | Portfolio news, Sep 2026 | $20M (SEC Form ADV) | 5 Nov 2026 | 6 names · Unlock |
| Equal Opportunity Ventures | VC firm | Cambridge, MA | Pre-seed | Medtech, Healthtech, Fintech, Food and Beverage | New deal, Apr 2026 | $152M (SEC Form ADV) | 5 Nov 2026 | 8 names · Unlock |
| 1616 Ventures | VC firm | Nashville, TN | Pre-seed | Medtech, Healthtech, SaaS | New fund, Aug 2026 | $150M (SEC Form D, 2026) | 4 Nov 2026 | 1 name · Unlock |
You are seeing 25 of 350. The full list adds 325 more firms and 1,731 named decision-makers.
This list is over 300 rows, so it is delivered inside US Complete. One-time payment. No subscription. No account.
Or get the free sample.
Need fewer rows than the whole file? The investor matching tool, opened here for medtech and medical devices and the US, builds a shortlist of up to 300 matching investors for $49, one-time.
How these 350 break down
By US state
| US state | On this list | Share |
|---|---|---|
| California | 92 | 26% |
| New York | 53 | 15% |
| Massachusetts | 37 | 11% |
| Texas | 24 | 7% |
| Illinois | 12 | 3% |
| Florida | 12 | 3% |
| Tennessee | 11 | 3% |
| Pennsylvania | 9 | 3% |
| Washington | 8 | 2% |
| Maryland | 7 | 2% |
Full lists, each with its own row count: Medtech investors in California (92)Medtech investors in New York (53)Medtech investors in Massachusetts (37)Medtech investors in Texas (25)
By stage
| Stage | On this list | Share |
|---|---|---|
| Pre-Seed | 92 | 26% |
| Seed | 204 | 58% |
| Series A | 76 | 22% |
| Series B | 36 | 10% |
| Growth | 69 | 20% |
Stage is our research. A firm can back more than one stage.
Full lists, each with its own row count: Pre-seed medtech investors in the US (95)Seed medtech investors in the US (205)Series A medtech investors in the US (76)Series B medtech investors in the US (36)Growth-stage medtech investors in the US (69)
By type
| Type | On this list | Share |
|---|---|---|
| VC firm | 342 | 98% |
| Corporate VC | 5 | 1% |
| Fund manager | 3 | 1% |
Method and limits
- Source
- 348 of the 350 rows carry an SEC filing (Form D or Form ADV). 347 of the 350 have a website we checked; the other 3 rest on the filing or register entry alone. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule
- Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. This list holds VC firms, fund managers and corporate venture arms; accelerators and angel networks are in their own lists. Sector: the firm states medtech and medical devices as a focus on its own site, or we observed it in the firm's portfolio.
- Order
- Firms with a published profile come first. Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stated focus on the US (15: full marks when the firm names the US as where it invests, half when it says global), size of the fund on file on a log scale (15) and completeness of the public record (10). Regional focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Last refreshed
- November 2026. Rows on this list were checked between 4 Nov 2026 and 6 Nov 2026.
- Fill rates
- Of 350 rows: stage 282, sector 350, fund size 316, website 347. In the paid file: named decision-makers on 334 rows, firm email on 112, LinkedIn page on 189, check size on 23.
- Corrections
- Email hello@theinvestordatabase.com or use the update form. We act within 5 working days.
Questions
How many medtech venture capital firms in the US are there?
We list 350 as of November 2026. 178 of the 350 have a fund filing or a dated deal in the last 12 months. The cities with the most are New York (47), San Francisco (25) and Boston (19).
Which medtech venture capital firms in the US raised a new fund in the last 12 months?
124 of the 350 have a fund filing dated in the last 12 months. The most recent on this list are Reveille (Nov 2026), 25Madison Ventures (Oct 2026) and SJF Ventures (Oct 2026).
What is the typical fund size of medtech venture capital firms in the US?
The median fund size on file for this list is $60M, across the 243 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 107 do not disclose a size there.
Which stage do most medtech venture capital firms in the US back?
Of the 282 with a stage on file, seed (204), pre-seed (92) and Series A (76). A firm can back more than one stage, and 68 rows have no stage on file yet.
Where does the data on medtech venture capital firms in the US come from and how often is it updated?
348 of the 350 rows have an SEC filing on file (Form D or Form ADV) and 2 were checked on the firm's own website or an official register. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 6 Nov 2026 at the latest. The whole file is re-verified twice a year.
Can I download the list of medtech venture capital firms in the US as a spreadsheet?
Yes. The file holds all 350 rows in Excel and CSV, with 1,731 named decision-makers and 112 firm emails, for $197 one-time as part of US Complete. 25 rows are free on this page.
Narrower lists
Seed medtech investors in the US (205)Pre-seed medtech investors in the US (95)Medtech investors in California (92)Medtech investors in the San Francisco Bay Area (76)Series A medtech investors in the US (76)Growth-stage medtech investors in the US (69)Medtech investors in New York (53)Medtech investors in Silicon Valley (40)Medtech investors in Massachusetts (37)Series B medtech investors in the US (36)Medtech investors in Texas (25)
Related lists
CPG venture capital firms in the US (130)Consumer venture capital firms in the US (348)Ecommerce venture capital firms in the US (69)Edtech venture capital firms in the US (83)Proptech venture capital firms in the US (96)Climate tech venture capital firms in the US (256)Deep tech venture capital firms in the US (322)Hardware venture capital firms in the US (272)Impact venture capital firms in the US (55)Food and beverage venture capital firms in the US (91)AI venture capital firms in the US (1,112)SaaS venture capital firms in the US (1,049)Healthtech venture capital firms in the US (709)Fintech venture capital firms in the US (525)Biotech venture capital firms in the US (297)Industrial tech venture capital firms in the US (267)B2B venture capital firms in the US (257)Energy venture capital firms in the US (249)
Not sure this is the right list? Describe your raise in the investor matching tool and get a shortlist. The link opens it set to medtech and medical devices and the US. Guide: how to build an investor list. Markdown version of this page.
Check the quality first
A free sample of 100 investors, every column, with sources and dates.